A. Thoren et al., Differential effects of dopamine, dopexamine, and dobutamine on jejunal mucosal perfusion early after cardiac surgery, CRIT CARE M, 28(7), 2000, pp. 2338-2343
Objective: To evaluate the potential differential effects of dopamine, dope
xamine, and dobutamine on jejunal mucosal perfusion, assessed by endolumina
l laser Doppler flowmetry in uncomplicated postcardiac surgical patients.
Design: A prospective, blinded, randomized, crossover study.
Setting: A cardiothoracic intensive care unit in a tertiary care center.
Patients: A total of ten postoperative cardiac surgical patients were studi
ed.
Interventions: Each patient received sequentially, randomly, and in a blind
ed fashion 2.7 +/- 0.2 mu g.kg(-1).min(-1) dopamine, 0.7 +/- 0.1 mu g.kg(-1
).min(-1) dopexamine, and 2.7 +/- 0.1 mu g.kg(-1).min(-1) dobutamine. Each
inotropic agent was titrated to increase cardiac output by 25% from baselin
e. Data on jejunal mucosal perfusion, splanchnic lactate, and oxygen extrac
tion were obtained during a 1-min control period and a B-min drug infusion
period after the target cardiac output was reached. The procedure was seque
ntially repeated for each agent, and there was a 20- to 30-min washout peri
od between each agent.
Measurements and Main Results: Dopamine, dopexamine, and dobutamine increas
ed jejunal mucosal perfusion by 27% (p < .01), 20% (p < .001), and 7% (p <
.001), respectively. The increase in jejunal mucosal perfusion by dopamine
and dopexamine were significantly more pronounced compared with dobutamine
(p < .05 and p < .01, respectively), whereas there was no difference betwee
n dopamine and dopexamine. Splanchnic oxygen extraction decreased to the sa
me extent with all three drugs. Splanchnic lactate extraction did not chang
e for any of the drugs. The effects on central hemodynamics were similar fo
r the three inotropic agents.
Conclusions: Endoluminal laser Doppler flowmetry is a new tool for the dete
ction of perfusion changes at the local intestinal mucosal level. Dopamine,
dopexamine, and dobutamine have differential effects on jejunal mucosal pe
rfusion probably because of their different receptor stimulating properties
. These findings may be of clinical importance when the therapeutic goal is
to improve gut mucosal perfusion.